About: Effect of continuous renal replacement therapy on all-cause mortality in COVID-19 patients undergoing invasive mechanical ventilation: a retrospective cohort study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effect of continuous renal replacement therapy on all-cause mortality in COVID-19 patients undergoing invasive mechanical ventilation: a retrospective cohort study Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Effect of continuous renal replacement therapy on all-cause mortality in COVID-19 patients undergoing invasive mechanical ventilation: a retrospective cohort study
Creator	Yang, Yi Xu, Gang Wang, Yanan Liu, Qingquan He, Fan Li, Junhua Ge, Shuwang Cheng, Anying Guo, Shuiming Ning, Yong Shi, Jia Xing, Xue
Source	MedRxiv
abstract	Background: Since December 2019, when coronavirus disease 2019 (COVID 19) emerged in Wuhan and rapidly spread throughout the world, critically ill patients have a high mortality rate. We aimed to assess the effect of continuous renal replacement therapy (CRRT) on all cause mortality in patients with COVID 19 undergoing invasive mechanical ventilation. Methods: In this retrospective cohort study, we included all patients with COVID 19 undergoing invasive mechanical ventilation at Optical Valley Branch of Tongji Hospital Affiliated with Tongji Medical College, Huazhong University of Science and Technology, Wuhan from February 12th to March 2nd, 2020. Demographic, clinical, laboratory, and treatment data were collected and analyzed. All patients were followed until death or end of follow up (March 9th), and all survivors were followed for at least one week. Findings: Of 36 hospitalized COVID-19 patients with invasive mechanical ventilation, the mean age was 69.4 (SD 1.8) years and 30 (83.3%) were men. 22 (61.1%) patients received CRRT (CRRT group) and 14 cases (38.9%) were managed in conventional strategy (non CRRT group). There was no difference in age, sex, comorbidities, complications, treatments and most of the laboratory findings, except for patients in the CRRT group with higher levels of aspartate aminotransferase and serum creatinine. During the average follow-up period of 10.4 days, 12 of 22 (54.5%) patients in CRRT group and 11 of 14 (78.6%) patients in non CRRT group died. Kaplan Meier analysis demonstrated a prolonged survival in patients in CRRT group than non CRRT group (P=0.032). The association between CRRT treatment and a reduced risk of mortality remained significant after adjusting for confounding factors in seven different models, with an adjusted hazard ratio (aHR) varying between 0.283 and 0.424. Older age, higher levels of IL1b, IL2 receptor, hs cTnI and NT proBNP were independently associated with increased risk of mortality in patients with CRRT treatment. Interpretation: CRRT may be beneficial for the treatment of COVID 19 patients with invasive mechanical ventilation. Further prospective multicenter studies with larger sample sizes are required.
has issue date	2020-03-20(xsd:dateTime)
bibo:doi	10.1101/2020.03.16.20036780
has license	medrxiv
sha1sum (hex)	4724fb5dae8558f878103d1ebf49c1431c28f113
schema:url	https://doi.org/10.1101/2020.03.16.20036780
resource representing a document's title	Effect of continuous renal replacement therapy on all-cause mortality in COVID-19 patients undergoing invasive mechanical ventilation: a retrospective cohort study
resource representing a document's body	covid:4724fb5dae8558f878103d1ebf49c1431c28f113#body_text
is schema:about of	named entity 'invasive' named entity 'mortality' named entity 'patients' named entity 'continuous' named entity 'PATIENTS' named entity 'WORLD' named entity 'all-cause mortality' named entity 'sample size' named entity 'acute respiratory distress syndrome' named entity 'CRRT' named entity 'troponin' named entity 'cTnI' named entity 'Fresenius' named entity 'NT-proBNP' named entity 'TNF-β' named entity 'invasive mechanical ventilation' named entity 'supportive treatment' named entity 'severe sepsis' named entity 'ultrafiltration' named entity 'acute respiratory distress syndrome' named entity 'CRRT' named entity 'medRxiv' named entity 'cytotoxins' named entity 'CRRT' named entity 'IL-10' named entity 'ADE' named entity 'COVID' named entity 'CRRT' named entity 'prognostic significance' named entity 'CRRT' named entity 'infection' named entity 'NT-proBNP' named entity 'renal function' named entity 'C-reactive protein' named entity 'coagulation' named entity 'confounding factors' named entity 'CRRT' named entity 'electrolyte disturbances' named entity 'IL-2' named entity 'cytotoxic action' named entity 'CRRT' named entity 'fluid overload' named entity 'viral pneumonia' named entity 'Inflammatory mediators' named entity 'follow-up' named entity 'IL-6' named entity 'white blood cell count' named entity 'sepsis' named entity 'severe sepsis' named entity 'CRRT' named entity 'interleukin (IL)-6' named entity 'acute kidney injury' named entity 'comorbidity' named entity 'medRxiv' named entity 'IL-1β' named entity 'Gambro' named entity 'diffusion' named entity 'COVID' named entity 'systemic inflammatory response' named entity 'solute' named entity 'coronaviruses' named entity '28 days' named entity 'IL-1β' named entity 'NT-proBNP' named entity 'peer review' named entity 'biological activity' named entity 'loss to follow-up' named entity 'proportional hazards regression' named entity 'interquartile range' named entity 'IL-2 receptor' named entity 'CRRT' named entity 'invasive mechanical ventilation' named entity 'coronavirus' named entity 'systemic inflammatory response'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software